Outgoing Novartis CEO Hunts for His Next Big Challenge Post author:Sam Post published:January 24, 2018 Post category:BioPharma Joseph Jimenez retires at the end of the month after eight years in the top job at Novartis. Source: BioSpace You Might Also Like Tax Reform Could Lead to Spike in Biopharma M&A Activity February 22, 2018 GlaxoSmithKline's Shingrix Approved in the U.S. for Prevention of Shingles in Adults Aged 50 and … October 22, 2017 AstraZeneca PLC Dumps Two Drugs From Pipeline, Causing an Ex-Partner's Stock to Tank Some More April 26, 2017
GlaxoSmithKline's Shingrix Approved in the U.S. for Prevention of Shingles in Adults Aged 50 and … October 22, 2017
AstraZeneca PLC Dumps Two Drugs From Pipeline, Causing an Ex-Partner's Stock to Tank Some More April 26, 2017